{"id":"W4380626300","doi":"10.1093/ndt/gfad063a_4140","title":"#4140 DAPRODUSTAT VERSUS RECOMBINANT HUMAN ERYTHROPOIETIN FOR TREATING ANAEMIA OF CHRONIC KIDNEY DISEASE: COST EFFECTIVENESS MODEL METHODOLOGY AND FINDINGS","year":2023,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Dialysis; Reimbursement; Darbepoetin alfa; Kidney disease; Erythropoietin; Intensive care medicine; Transplantation; Epoetin alfa; Hemodialysis; Adverse effect; Kidney transplantation; Clinical trial; Internal medicine; Health care","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004735881,0.00165671,0.002698053,0.002125516,0.0006471928,0.002602977,0.002442666,0.002544904,0.01492702],"category_scores_gemma":[0.01070695,0.001091241,0.002592361,0.002136948,0.0007450862,0.001213871,0.001115632,0.002217155,0.0005337315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01109285,"about_ca_system_score_gemma":0.01106813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1564844,"about_ca_topic_score_gemma":0.0725636,"domain_scores_codex":[0.9980039,0.001264173,0.00005175161,0.000175522,0.0001694784,0.000335114],"domain_scores_gemma":[0.992444,0.006540573,0.0003037156,0.00006442595,0.0004304829,0.0002167911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0004814596,0.0001279029,0.001711679,0.000233564,0.0002362419,0.00008284127,0.00001920877,0.9816298,0.00006947373,0.009261602,0.001823097,0.00432308],"study_design_scores_gemma":[0.0005549453,0.0002542348,0.0009106545,0.000114887,0.0003086699,0.00003782536,0.00004881447,0.9908343,0.00007154244,0.005260459,0.001579075,0.0000246647],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5641149,0.01064382,0.2175784,0.01541618,0.0005321041,0.008348761,0.05130699,0.0008355543,0.1312231],"genre_scores_gemma":[0.9359907,0.003152132,0.03305778,0.000889665,0.0001255923,0.004097962,0.004724302,0.0000653757,0.0178964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1564844,"threshold_uncertainty_score":0.3111471,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05951601111721236,"score_gpt":0.3551979399087446,"score_spread":0.2956819287915322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}